Early research (Phase 1)Looking for participantsNCT05010564What this trial is testingTrivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)Who this might be right forLeukemia, B-Cell Baylor College of Medicine 38
Large-scale testing (Phase 3)Study completedNCT03734016What this trial is testingZanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma BeiGene 652
Very early researchUnknownNCT03895944What this trial is testingET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and LymphomaWho this might be right forCD19+ Lymphoma, B-CellCD19+ Leukemia, B-Cell First Affiliated Hospital Xi'an Jiaotong University 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07624799What this trial is testingFixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).Who this might be right forCLL (Chronic Lymphocytic Leukemia) French Innovative Leukemia Organisation 82
Testing effectiveness (Phase 2)Study completedNCT00103558What this trial is testingLumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Biogen 31
Large-scale testing (Phase 3)Ended earlyNCT00014326What this trial is testingInvolved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 204
Testing effectiveness (Phase 2)Study completedNCT00867529What this trial is testingRituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00431873What this trial is testingA Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic LeukemiaWho this might be right forLymphocytic Leukemia, Chronic Mirati Therapeutics Inc. 21
Early research (Phase 1)Study completedNCT02996773What this trial is testingHaploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineWho this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more University of Arizona 50
Early research (Phase 1)Study completedNCT00003294What this trial is testingChemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT04605666What this trial is testingCD19-CAR-T2 Cells for CD19 Positive B Cell MalignanciesWho this might be right forB Cell LeukemiaB Cell Lymphoma Nanfang Hospital, Southern Medical University 77
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT02912754What this trial is testingRuxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia PatientsWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Sunnybrook Health Sciences Centre 36
Early research (Phase 1)UnknownNCT03383952What this trial is testingA Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and LeukemiaWho this might be right forB Cell LeukemiaB Cell Lymphoma Immune Cell, Inc. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408What this trial is testingAsciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CMLWho this might be right forPh+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more The University of Hong Kong
Early research (Phase 1)WithdrawnNCT02657447What this trial is testingDosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)Who this might be right forNon-Hodgkin Lymphoma Nordic Nanovector
Testing effectiveness (Phase 2)WithdrawnNCT04282174What this trial is testingCD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic MalignanciesWho this might be right forHematologic DiseasesHematologic MalignancyAcute Lymphoblastic Leukemia+3 more Baptist Health South Florida
Large-scale testing (Phase 3)UnknownNCT01217723What this trial is testingThymoglobulin in Unrelated Hematopoietic Progenitor Cell TransplantationWho this might be right forHematologic Malignancies McMaster University 198
Testing effectiveness (Phase 2)Ended earlyNCT01045382What this trial is testingMSC and HSC Coinfusion in Mismatched MinitransplantsWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myelocytic, Chronic+6 more University of Liege 39